e-Article
Overall survival and patient-reported outcome results from the placebo-controlled randomized phase III IMagyn050/GOG 3015/ENGOT-OV39 trial of atezolizumab for newly diagnosed stage III/IV ovarian cancer
Document Type
Article
Author
Pignata, Sandro; Bookman, Michael; Sehouli, Jalid; Miller, Austin; Penson, Richard T.; Taskiran, Cagatay; Anderson, Charles; Hietanen, Sakari; Myers, Tashanna; Madry, Radoslaw; Willmott, Lyndsay; Lortholary, Alain; Thomes-Pepin, Jessica; Aghajanian, Carol; McCourt, Carolyn; Stuckey, Ashley; Wu, Xiaohua; Nishio, Shin; Copeland, Larry J.; He, Yvette; Molinero, Luciana; Patel, Sheetal; Lin, Yvonne G.; Khor, Victor K.; Moore, Kathleen N.
Source
In Gynecologic Oncology October 2023 177:20-31
Subject
Language
ISSN
0090-8258